Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Hepatitis in Prisoners: A Systematic Review of Current Evidence Publisher Pubmed



Pashangzadeh S1 ; Seyedalinaghi S1 ; Dadras O2 ; Pashaei Z1 ; Soleymanzadeh M3 ; Barzegary A4 ; Mirzapour P1 ; Vahedi F5 ; Fakhfouri A4 ; Noori T6 ; Irani SMH7 ; Mehraeen E7 ; Jahanfar S8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Section Global Health and Rehabilitation, Western Norway University and Applied Sciences, Bergen, Norway
  3. 3. School of Medicine, Ophthalmology Resident at Farabi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  4. 4. School of Medicine, Islamic Azad University, Tehran, Iran
  5. 5. School of Medi-cine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Health Information Technology, Zabol University of Medical Sciences, Zabol, Iran
  7. 7. Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran
  8. 8. Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States

Source: Infectious Disorders - Drug Targets Published:2022


Abstract

Introduction: Prisoners represent high-risk behaviors such as injecting drug use, sharing syringes, tattooing, and unprotected sexual intercourse. The authors aimed to study the prevalence of hepatitis B, hepatitis C, and hepatitis D in the prisoners. Methods: We conducted a systematic search using the keywords in online databases of PubMed, Web of Science, Scopus, and Science Direct. Two independent researchers examined the quality of the articles and the probable risk of bias. The most relevant articles by title and abstract were retrieved. Final-ly, the full text of selected articles was read, and the critical findings were extracted. Results: Reviews of 23 studies showed that most prisoners are susceptible to hepatitis B and hepatitis C. One study also indicated that prisoners could be infected with hepatitis A and hepatitis E. The most common routes of hepatitis transmission in prisons were intravenous drug use, needle sharing, tattoo-ing, and unsafe sex with multiple sexual partners. Conclusion: High-risk sexual behaviors, shared contaminated needles for IV drug injection, and tattooing are the principal routes of hepatitis transmission among prison inmates. Hepatitis treatment is feasible and could be useful for infected prisoners undergoing a well-designed treatment program. © 2022 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates, Epidemiologic Reviews (2018)
2. Global Burden of Hiv, Viral Hepatitis, and Tuberculosis in Prisoners and Detainees, The Lancet (2016)
3. Hiv Prevalence and Correlations in Prisons in Different Regions of the World: A Review Article, Open AIDS Journal (2018)
4. An Intervention to Increase Hepatitis C Virus Diagnosis and Treatment Uptake Among People in Custody in Iran, International Journal of Drug Policy (2021)
5. Continuum of Hepatitis C Care Cascade in Prison and Following Release in the Direct-Acting Antivirals Era, Harm Reduction Journal (2020)
6. Hiv Prevalence Among People Who Inject Drugs (Pwid) and Related Factors in Iran: A Systematic Review, Meta-Analysis and Trend Analysis, Addiction (2020)
7. People Who Inject Drugs in Prison: Hiv Prevalence, Transmission and Prevention, International Journal of Drug Policy (2015)
8. Prevalence of Sexually Transmitted Infections and Associated Risk Behaviors in Prisoners: A Systematic Review, Health Science Reports (2022)
Experts (# of related papers)
View all Related Experts
Seyed Ahmad Seyed Alinaghi (9)
Hossein Poustchi (6)
Other Related Docs
9. Prevalence of Hepatitis C Virus Infection Among High-Risk Groups in Iran: A Systematic Review and Meta-Analysis, Public Health (2018)
10. Global Prevalence, Cascade of Care, and Prophylaxis Coverage of Hepatitis B in 2022: A Modelling Study, The Lancet Gastroenterology and Hepatology (2023)
11. Prevalence and Associated Factors of Hiv Infection Among Male Prisoners in Tehran, Iran, Archives of Iranian Medicine (2017)
12. Correlates of Injecting Paraphernalia Sharing Among Male Drug Injectors in Kermanshah, Iran: Implications for Hcv Prevention, Journal of Substance Use (2020)
13. High Hepatitis C Virus Prevalence Among Drug Users in Iran: Systematic Review and Meta-Analysis of Epidemiological Evidence (2001-2012), International Journal of Infectious Diseases (2015)
14. High Hiv Prevalence in a Respondent-Driven Sampling Survey of Injection Drug Users in Tehran, Iran, AIDS and Behavior (2015)
15. Hiv in Iran: Onset, Responses, and Future Directions, AIDS (2021)
16. Significance of Hepatitis E Virus Infection in Hiv-Infected Patients: A Challenging Issue, Asian Pacific Journal of Tropical Disease (2015)
17. A Simple Risk-Based Strategy for Hepatitis C Virus Screening Among Incarcerated People in a Low- to Middle-Income Setting, Harm Reduction Journal (2020)
18. Prevalence of Sexually Transmitted Infections (Stis) and Related Factors Among Female Prisoners in Tehran, Iran, International Journal of Prisoner Health (2023)
19. Epidemiology of Hepatitis B in Iran From 2000 to 2016: A Systematic Review and Meta-Regression Analysis, Archives of Iranian Medicine (2020)
20. Hepatitis B Virus Infection Among People Who Use Drugs in Iran: A Systematic Review, Meta-Analysis, and Trend Analysis, Harm Reduction Journal (2020)
21. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
22. Molecular Mechanisms Responsible for Occult Hepatitis B Virus Infection, Govaresh (2019)
23. Transition to Injecting Drug Use in Iran: A Systematic Review of Qualitative and Quantitative Evidence, International Journal of Drug Policy (2015)
24. Profile of People Who Inject Drugs in Tehran, Iran, Acta Medica Iranica (2016)
25. Impact of Hiv Infection in Patients Infected With Chronic Hcv (Genotypes 1A and 3A): Virological and Clinical Changes, Pathogens and Global Health (2016)
26. Sociodemographic Characteristics, Hiv-Related Risk Behaviors and Hiv Prevalence of Vulnerable Men in Tehran, Iran, Current HIV Research (2021)
27. Hiv-Related Risk Behaviors Among Male Inmates of Tehran, Iran, Asian Pacific Journal of Tropical Disease (2016)
28. Social Determinants and Hepatitis C Among People Who Inject Drugs in Kermanshah, Iran: Socioeconomic Status, Homelessness, and Sufficient Syringe Coverage, Journal of Substance Use (2017)
29. Hepatitis C Virus Infection in Iran: A Review of Current Prevalence and Preventive Strategies From a Developing Country, Journal of Clinical Virology Plus (2024)
30. Prevalence of Hepatitis B and C Infections and Associated Risk Factors in Pars Cohort Study, Southern Iran, Middle East Journal of Digestive Diseases (2021)
31. Hiv and Risk Behaviors Among Visitors of Inmates at the Great Tehran Prison, Iran, 2018, Open AIDS Journal (2020)
32. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)